IHH Annual Report 2024

217 38. SUBSIDIARIES Details of subsidiaries are as follows: Name of subsidiary Place of incorporation and business Principal activities Effective ownership interest and voting interest 2024 % 2023 % Direct subsidiaries Integrated Healthcare Holdings Limited # Federal Territory of Labuan Malaysia Investment holding 100 100 Integrated Healthcare Turkey Yatirimlari Limited # Federal Territory of Labuan Malaysia Investment holding 100 100 IHH Financial Services Pte. Ltd. Singapore Treasury centre 100 100 IHH Laboratories Holdings Sdn. Bhd. # Malaysia Investment holding 100 100 Indirect subsidiaries Held through Integrated Healthcare Holdings Limited: Parkway Pantai Limited Singapore Investment holding 100 100 Held through Integrated Healthcare Turkey Yatirimlari Limited: Integrated Healthcare Hastaneler Turkey Sdn. Bhd. # Malaysia Investment holding 100 100 Held through IHH Laboratories Holdings Sdn. Bhd.: IHH Laboratories Pte. Ltd. Singapore Investment holding and provision of services for medical diagnostic laboratory tests 100 100 Held through Parkway Pantai Limited: Parkway HK Holdings Limited (1) Hong Kong Investment holding 100 100 Parkway Holdings Limited Singapore Investment holding 100 100 Pantai Holdings Sdn. Bhd. # Malaysia Investment holding 100 100 Parkway Group Healthcare Pte. Ltd. (2) Singapore Investment holding and provision of technical support services 100 100 Gleneagles Development Pte. Ltd. (3) Singapore Investment holding 100 100 Parkway Healthcare Indo-China Pte. Ltd. Singapore Investment holding 100 100 Northern TK Venture Pte. Ltd. Singapore Investment holding 100 100

RkJQdWJsaXNoZXIy NDgzMzc=